Director, President and Chief Executive Officer of CareDx Age: 4 6 Director since 2024 Professional Experience President and Chief Executive Officer, CareDx, Inc. (2024 - Present) Vice President, Corporate Development (Pacific Biosciences of California, Inc. (2023 2024) CEO, Apton Biosystem, Inc. (2021 2023) Chief Commercial Officer, Veracyte, Inc. (2011 2021) Key Skills & Qualifications Relevant Industry Knowledge: Mr. Hanna has over two decades of experience in the molecular diagnostics and life sciences tools industries. Business and Operations Leadership Experience: Mr. Hanna previously served as CEO of Apton Biosystems, Inc. where he led the development of a high throughput next-generation sequencing (NGS) platform for liquid biopsy and other clinical applications. The company was acquired by Pacific Biosciences of California, Inc. in August 2023, where he served as Vice President of Corporate Development. Mr. Hanna previously spent ten years at Veracyte, Inc., an oncology diagnostics company in the fields of thyroid, lung, breast, and prostate cancer, where he held numerous roles including Chief Commercial Office and Vice President of Marketing. Prior to Veracyte, Mr. Hanna held leadership roles at Humana and IBM. Current Organization CareDx, Inc. Previous Organizations Pacific Biosciences of California, Inc. Apton Biosystem, Inc. Veracyte, Inc. Education M.B.A., University of Miami B.S. (Political Science), Hampden Sydney College